Analysis of serum adenosine deaminase (ADA) and ADA1 and ADA2 isoenzyme activities in HIV positive and HIV-HBV co-infected patients

Clinical Biochemistry

Volumn 44, Issue 12, 2011, Pages 980-983

  Khodadadi, Iraj ^a   Abdi, Mohammad ^b   Ahmadi, Abbas ^b   Wahedi, Mohammad Saleh ^b   Menbari, Shahoo ^b   Lahoorpour, Fariba ^b   Rahbari, Rezgar ^c  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adenosine deaminase; Hepatitis B virus; Human immunodeficiency virus; Isoenzymes

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASE 1; ADENOSINE DEAMINASE 2; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; ISOENZYME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; COMORBIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; COST BENEFIT ANALYSIS; DIAGNOSTIC TEST; ENZYME ACTIVITY; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOSINE DEAMINASE; ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; HEPATITIS B; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; ISOENZYMES; MALE; MIDDLE AGED;

EID: 79960319698     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.05.020     Document Type: Article

References (36)

1. Phillis J.W. Adenosine and adenine nuleotides as regulators of cellular function 1991, CRC press, Boca Raton, Florida, U.S.A. first ed.
2. Conway E.J., Cooke R. The deaminases of adenosine and adenylic acid in blood and tissues. Biochem J 1939, 33(4):479-492.
3. Van der Weyden M.B., Kelley W.N. Human adenosine deaminase. Distribution and properties. J Biol Chem 1976, 251(18):5448-5456.
4. Adams A., Harkness R.A. Adenosine deaminase activity in thymus and other human tissues. Clin Exp Immunol 1976, 26(3):647-649.
5. Zidek Z. Adenosine - cyclic AMP pathways and cytokine expression. Eur Cytokine Netw 1999, 10(3):319-328.
6. Gakis C. Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: diagnostic and biological role. Eur Respir J 1996, 9(4):632-633.
7. Ungerer J.P., Oosthuizen H.M., Bissbort S.H., Vermaak W.J. Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem 1992, 38(7):1322-1326.
8. Goodarzi M.T., Abdi M., Tavilani H., Rashidi M. Adenosine deaminase activity in COPD patients and healthy subjects. Iran J Allergy Asthma Immunol 2010, 9(1):7-12.
9. Zuckerman S.H., Olson J.M., Douglas S.D. Adenosine deaminase activity during in vitro culture of human peripheral blood monocytes and pulmonary alveolar macrophages. Exp Cell Res 1980, 129(2):281-287.
10. Poursharifi P., Saghiri R., Ebrahimi-Rad M., et al. Adenosine deaminase in patients with primary immunodeficiency syndromes: the analysis of serum ADA1 and ADA2 activities. Clin Biochem 2009, 42(13-14):1438-1443.
11. Delia S., Mastroianni C.M., Massetti A.P., et al. Adenosine deaminase activity and acquired immunodeficiency syndrome (AIDS). Clin Chem 1987, 33(9):1675.
12. Niedzwicki J.G., Kouttab N.M., Mayer K.H., et al. Plasma adenosine deaminase2: a marker for human immunodeficiency virus infection. J Acquir Immune Defic Syndr 1991, 4(2):178-182.
13. Tsuboi I., Sagawa K., Shichijo S., Yokoyama M.M., Ou D.W., Wiederhold M.D. Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections. Clin Diagn Lab Immunol 1995, 2(5):626-630.
14. Valls V., Ena J., Roca V., Perez-Oteyza C., Angeles Figueredo M., Enriquez-de-Salamanca R. Significance of adenosine deaminase measurement in sera of patients with HIV-1 infection. AIDS 1990, 4(4):365-366.
15. Corral I., Quereda C., Navas E., et al. Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis. Eur J Clin Microbiol Infect Dis 2004, 23(6):471-476.
16. Piras M.A., Gakis C., Budroni M., Andreoni G. Immunological studies in Mediterranean spotted fever. Lancet 1982, 1(8283):1249.
17. Galanti B., Nardiello S., Russo M., Fiorentino F. Increased lymphocyte adenosine deaminase in typhoid fever. Scand J Infect Dis 1981, 13(1):47-50.
18. Branson B., Handsfield H., Lampe M., et al. CDC, Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings. MMWR 2006, 55(RR14):1-17.
19. Weinbaum C., Williams I., Mast E., et al. CDC, Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection. MMWR 2008, 57(RR08):1-20.
20. Giusti G. Adenosine deaminase. Methods of enzymatic analysis 1984, Vol 4. VCH Weinheim, Florida. Third ed. H. Bergmeyer (Ed.).
21. van Laarhoven J.P., de Bruyn C.H. Purine metabolism in relation to leukemia and lymphoid cell differentiation. Leuk Res 1983, 7(4):451-480.
22. VanLaarhoven J.P.R.M., Spierenburg G.T., Collet H., Delespesse G., De Bruyn C.H.M.M. Purine interconversion pathway in T, B, Tg and T-Tg cells from human peripheral blood. Adv Exp Med Biol 1984, 165:111-118.
23. Sari R.A., Taysi S., Yilmaz O., Bakan N. Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin Exp Rheumatol 2003, 21(1):87-90.
24. Taysi S., Polat M.F., Sari R.A., Bakan E. Serum adenosine deaminase and cytidine deaminase activities in patients with systemic lupus erythematosus. Clin Chem Lab Med 2002, 40(5):493-495.
25. Yoneyama Y., Sawa R., Suzuki S., Otsubo Y., Araki T. Serum adenosine deaminase activity in women with hyperemesis gravidarum. Clinica chimica acta 2002, 324(1-2):141-145.
26. Kaya S., Cetin E.S., Aridogan B.C., Arikan S., Demirci M. Adenosine deaminase activity in serum of patients with hepatitis - a useful tool in monitoring clinical status. J Microbiol Immunol Infect 2007, 40(4):288-292.
27. Kalkan A., Bulut V., Erel O., Avci S., Bingol N.K. Adenosine deaminase and guanosine deaminase activities in sera of patients with viral hepatitis. Mem Inst Oswaldo Cruz 1999, 94(3):383-386.
28. Nardiello S., Russo M., Pizzella T., Galanti B. Different levels of lymphocyte adenosine deaminase in active and inactive forms of chronic liver disease. J Clin Lab Immunol 1983, 11(4):177-180.
29. Salvatore D., Claudio M.M., Anna M.P., et al. Adenosine deaminase activity and acquired immunodeficiency syndrome (AIDS). Clin Chem 1987, 33:1675.
30. Fozard J.R., Hannon J.P. Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD. Pulm Pharmacol Ther 1999, 12(2):111-114.
31. Prince H.E., Kleinman S., Czaplicki C., John J., Williams A.E. Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection. J Acquir Immune Defic Syndr 1990, 3(5):525-530.
32. Seligmann M. Immunology of infection with the human immunodeficiency virus. Recenti Prog Med 1988, 79(7-8):330-337.
33. Seligmann M., Pinching A.J., Rosen F.S., et al. Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Ann Intern Med 1987, 107(2):234-242.
34. Ge J., Wang K., Meng Q.H., Qi Z.X., Meng F.L., Fan Y.C. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol 2009, 30(1):60-67.
35. Hess G., Rossol S., Voth R., et al. Treatment of patients with chronic type B hepatitis and concurrent human immunodeficiency virus infection with a combination of interferon alpha and azidothymidine: a pilot study. Digestion 1989, 43(1-2):56-59.
36. Chittiprol S., Satishchandra P., Bhimasenarao S.R., et al. Plasma adenosine deaminase activity among HIV1 Clade C seropositives: relation to CD4 T cell population and antiretroviral therapy. Clinica Chimica Acta 2007, 377:133-137.